These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

774 related items for PubMed ID: 24419085

  • 21. Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells.
    Buechner J, Henriksen JR, Haug BH, Tømte E, Flaegstad T, Einvik C.
    Differentiation; 2011 Jan; 81(1):25-34. PubMed ID: 20980091
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A SP1/MIZ1/MYCN repression complex recruits HDAC1 at the TRKA and p75NTR promoters and affects neuroblastoma malignancy by inhibiting the cell response to NGF.
    Iraci N, Diolaiti D, Papa A, Porro A, Valli E, Gherardi S, Herold S, Eilers M, Bernardoni R, Della Valle G, Perini G.
    Cancer Res; 2011 Jan 15; 71(2):404-12. PubMed ID: 21123453
    [Abstract] [Full Text] [Related]

  • 26. Transcriptional repression of SKP2 is impaired in MYCN-amplified neuroblastoma.
    Muth D, Ghazaryan S, Eckerle I, Beckett E, Pöhler C, Batzler J, Beisel C, Gogolin S, Fischer M, Henrich KO, Ehemann V, Gillespie P, Schwab M, Westermann F.
    Cancer Res; 2010 May 01; 70(9):3791-802. PubMed ID: 20424123
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.
    Wang Q, Hii G, Shusterman S, Mosse Y, Winter CL, Guo C, Zhao H, Rappaport E, Hogarty MD, Maris JM.
    Cancer Res; 2003 Apr 01; 63(7):1631-5. PubMed ID: 12670915
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. p53 is a direct transcriptional target of MYCN in neuroblastoma.
    Chen L, Iraci N, Gherardi S, Gamble LD, Wood KM, Perini G, Lunec J, Tweddle DA.
    Cancer Res; 2010 Feb 15; 70(4):1377-88. PubMed ID: 20145147
    [Abstract] [Full Text] [Related]

  • 32. Expression and DNA-binding activity of MYCN/Max and Mnt/Max during induced differentiation of human neuroblastoma cells.
    Smith AG, Popov N, Imreh M, Axelson H, Henriksson M.
    J Cell Biochem; 2004 Aug 15; 92(6):1282-95. PubMed ID: 15258910
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Dickkopf-1 is down-regulated by MYCN and inhibits neuroblastoma cell proliferation.
    Koppen A, Ait-Aissa R, Hopman S, Koster J, Haneveld F, Versteeg R, Valentijn LJ.
    Cancer Lett; 2007 Oct 28; 256(2):218-28. PubMed ID: 17643814
    [Abstract] [Full Text] [Related]

  • 36. Lysine-specific demethylase (LSD1/KDM1A) and MYCN cooperatively repress tumor suppressor genes in neuroblastoma.
    Amente S, Milazzo G, Sorrentino MC, Ambrosio S, Di Palo G, Lania L, Perini G, Majello B.
    Oncotarget; 2015 Jun 10; 6(16):14572-83. PubMed ID: 26062444
    [Abstract] [Full Text] [Related]

  • 37. Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation.
    Rettig I, Koeneke E, Trippel F, Mueller WC, Burhenne J, Kopp-Schneider A, Fabian J, Schober A, Fernekorn U, von Deimling A, Deubzer HE, Milde T, Witt O, Oehme I.
    Cell Death Dis; 2015 Feb 19; 6(2):e1657. PubMed ID: 25695609
    [Abstract] [Full Text] [Related]

  • 38. Bmi-1 is essential for the tumorigenicity of neuroblastoma cells.
    Cui H, Hu B, Li T, Ma J, Alam G, Gunning WT, Ding HF.
    Am J Pathol; 2007 Apr 19; 170(4):1370-8. PubMed ID: 17392175
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells.
    Schulte JH, Lindner S, Bohrer A, Maurer J, De Preter K, Lefever S, Heukamp L, Schulte S, Molenaar J, Versteeg R, Thor T, Künkele A, Vandesompele J, Speleman F, Schorle H, Eggert A, Schramm A.
    Oncogene; 2013 Feb 21; 32(8):1059-65. PubMed ID: 22484425
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 39.